These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15508777)

  • 1. In-vitro interaction of tafenoquine and chloroquine in Plasmodium falciparum from northwestern Thailand.
    Vollnberg A; Prajakwong S; Sirichaisinthop J; Wiedermann G; Wernsdorfer G; Wernsdorfer WH
    Wien Klin Wochenschr; 2003; 115 Suppl 3():28-32. PubMed ID: 15508777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro response of Plasmodium falciparum to the main alkaloids of Cinchona in northwestern Thailand.
    Knauer A; Sirichaisinthop J; Reinthaler FF; Wiedermann G; Wernsdorfer G; Wernsdorfer WH
    Wien Klin Wochenschr; 2003; 115 Suppl 3():39-44. PubMed ID: 15508779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro sensitivity testing of Plasmodium vivax: response to lumefantrine and chloroquine in northwestern Thailand.
    Lux D; Prajakwong S; Kollaritsch H; Wernsdorfer G; Wernsdorfer WH
    Wien Klin Wochenschr; 2003; 115 Suppl 3():50-4. PubMed ID: 15508781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand.
    Pilz JB; Wernsdorfer G; Sirichaisinthop J; Rojanawatsirivet C; Wiedermann G; Wernsdorfer WH
    Wien Klin Wochenschr; 2004; 116 Suppl 4():41-6. PubMed ID: 15683042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the in-vitro activity of amodiaquine and its main metabolite, monodesethyl-amodiaquine, in Plasmodium falciparum.
    Gerstner U; Prajakwong S; Wiedermann G; Sirichaisinthop J; Wernsdorfer G; Wernsdorfer WH
    Wien Klin Wochenschr; 2003; 115 Suppl 3():33-8. PubMed ID: 15508778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and parasitological response of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in rural Uganda.
    Ogwang S; Engl M; Vigl M; Kollaritsch H; Wiedermann G; Wernsdorfer WH
    Wien Klin Wochenschr; 2003; 115 Suppl 3():45-9. PubMed ID: 15508780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
    Walsh DS; Eamsila C; Sasiprapha T; Sangkharomya S; Khaewsathien P; Supakalin P; Tang DB; Jarasrumgsichol P; Cherdchu C; Edstein MD; Rieckmann KH; Brewer TG
    J Infect Dis; 2004 Oct; 190(8):1456-63. PubMed ID: 15378438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of tafenoquine alone and in combination with artemisinin against Plasmodium falciparum.
    Ramharter M; Noedl H; Thimasarn K; Wiedermann G; Wernsdorfer G; Wernsdorfer WH
    Am J Trop Med Hyg; 2002 Jul; 67(1):39-43. PubMed ID: 12363062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum.
    Kreidenweiss A; Kremsner PG; Dietz K; Mordmüller B
    Am J Trop Med Hyg; 2006 Dec; 75(6):1178-81. PubMed ID: 17172389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished Plasmodium falciparum sensitivity to quinine exposure in vitro and in a sequential multi-drug regimen: A preliminary investigation in Guyana, South America.
    Best Plummer W; Pinto Pereira L
    Int J Infect Dis; 2008 Nov; 12(6):e27-31. PubMed ID: 18573671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluctuation in the resistance of Plasmodium falciparum to chloroquine in China].
    Liu DQ; Feng XP; Yang HL; Lin SG; Chen WJ; Yang PF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb; 23(1):27-31. PubMed ID: 16042203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Plasmodium falciparum isolates to chloroquine and mefloquine in southeastern Mindanao Island, the Philippines.
    Hatabu T; Kawazu S; Suzuki J; Valenzuela RF; Villacorte EA; Suzuki M; Rivera PT; Kano S
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):546-51. PubMed ID: 15115125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in chloroquine resistance of Plasmodium falciparum in Hainan province].
    Liu D; Cai X; Ren D; Liu R; Lin S; Zeng L; Tang X
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(1):32-4. PubMed ID: 12563813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of tafenoquine against the asexual blood stages of Plasmodium falciparum isolates from Gabon, Senegal, and Djibouti.
    Pradines B; Mamfoumbi MM; Tall A; Sokhna C; Koeck JL; Fusai T; Mosnier J; Czarnecki E; Spiegel A; Trape JF; Kombila M; Rogier C
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3225-6. PubMed ID: 16940138
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas.
    Mohapatra PK; Prakash A; Taison K; Negmu K; Gohain AC; Namchoom NS; Wange D; Bhattacharyya DR; Goswami BK; Borgohain BK; Mahanta J
    Trop Med Int Health; 2005 May; 10(5):478-83. PubMed ID: 15860095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border.
    Rojanawatsirivet C; Congpuong K; Vijaykadga S; Thongphua S; Thongsri K; Bangchang KN; Wilairatana P; Wernsdorfer WH
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):560-5. PubMed ID: 15689066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
    Hale BR; Owusu-Agyei S; Fryauff DJ; Koram KA; Adjuik M; Oduro AR; Prescott WR; Baird JK; Nkrumah F; Ritchie TL; Franke ED; Binka FN; Horton J; Hoffman SL
    Clin Infect Dis; 2003 Mar; 36(5):541-9. PubMed ID: 12594633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interaction between atovaquone and retinol in Plasmodium falciparum in vitro.
    Exner B; Wernsdorfer G; Sirichaisinthop J; Rojanawatsirivet C; Kollaritsch H; Wernsdorfer WH
    Wien Klin Wochenschr; 2007; 119(19-20 Suppl 3):45-52. PubMed ID: 17987358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the therapeutic efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum malaria in a tribal block of the Kalahandi district of Orissa, India.
    Kerketta AS; Mohapatra SS; Kar SK
    Trop Doct; 2008 Apr; 38(2):82-4. PubMed ID: 18453492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.